Scott Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Scott Capital Advisors's LLY Position: Q3 2026 in Review
Scott Capital Advisors reduced its Eli Lilly (LLY) stake by 26% in Q3 2026, selling an estimated $82.6K and leaving 200 shares worth $238K. The position accounts for 0.03% of the portfolio, ranked #68.
Scott Capital Advisors first reported a position in LLY in Q3 2023 and has held it in 13 quarters since. The position peaked at $695K in Q3 2025. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Scott Capital Advisors held 200 shares of Eli Lilly worth $238K as of Q3 2026.
- Scott Capital Advisors sold 70 Eli Lilly shares in Q3 2026, an estimated $82.6K.
- Eli Lilly made up 0.03% of Scott Capital Advisors's portfolio in Q3 2026, its #68 holding.
- Scott Capital Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 13 quarters since.
- Scott Capital Advisors's Eli Lilly position peaked at $695K in Q3 2025.
- 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Scott Capital Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.